tetano
Editor, Senior Moderator
- Sci Rep
- . 2020 Aug 7;10(1):13318.
- doi: 10.1038/s41598-020-70135-6.
- A panel of anti-influenza virus nucleoprotein antibodies selected from phage-displayed synthetic antibody libraries with rapid diagnostic capability to distinguish diverse influenza virus subtypes
Chung-Ming Yu[SUP] 1 [/SUP], Ing-Chien Chen[SUP] 1 [/SUP], Chao-Ping Tung[SUP] 1 [/SUP], ****-Pin Peng[SUP] 1 [/SUP], Jhih-Wei Jian[SUP] 1 [/SUP], Yi-Kai Chiu[SUP] 1 [/SUP], Yueh-Liang Tsou[SUP] 1 [/SUP], Hong-Sen Chen[SUP] 1 [/SUP], Yi-Jen Huang[SUP] 1 [/SUP], Wesley Wei-Wen Hsiao[SUP] 1 [/SUP], Yong Alison Wang[SUP] 2 [/SUP], An-Suei Yang[SUP] 3 [/SUP]
Affiliations
- PMID: 32770098
- DOI: 10.1038/s41598-020-70135-6
Abstract
Immunoassays based on sandwich immuno-complexes of capture and detection antibodies simultaneously binding to the target analytes have been powerful technologies in molecular analyses. Recent developments in single molecule detection technologies enable the detection limit of the sandwich immunoassays approaching femtomolar (10[SUP]-15[/SUP] M), driving the needs of developing sensitive and specific antibodies for ever-increasingly broad applications in detecting and quantifying biomarkers. The key components underlying the sandwich immunoassays are antibody-based affinity reagents, for which the conventional sources are mono- or poly-clonal antibodies from immunized animals. The downsides of the animal-based antibodies as affinity reagents arise from the requirement of months of development timespan and limited choices of antibody candidates due to immunodominance of humoral immune responses in animals. Hence, developing animal antibodies capable of distinguishing highly related antigens could be challenging. To overcome the limitation imposed by the animal immune systems, we developed an in vitro methodology based on phage-displayed synthetic antibody libraries for diverse antibodies as affinity reagents against closely related influenza virus nucleoprotein (NP) subtypes, aiming to differentiating avian influenza virus (H5N1) from seasonal influenza viruses (H1N1 and H3N2), for which the NPs are closely related by 90-94% in terms of pairwise amino acid sequence identity. We applied the methodology to attain, within four weeks, a panel of IgGs with distinguishable specificities against a group of representative NPs with pairwise amino acid sequence identities up to more than 90%, and the antibodies derived from the antibody libraries without further affinity refinement had comparable affinity of mouse antibodies to the NPs with the detection limit less than 1 nM of viral NP from lysed virus with sandwich ELISA. The panel of IgGs were capable of rapidly distinguishing infections due to virulent avian influenza virus from infections of seasonal flu, in responding to a probable emergency scenario where avian influenza virus would be transmissible among humans overlapping with the seasonal influenza infections. The results indicate that the in vitro antibody development methodology enables developing diagnostic antibodies that would not otherwise be available from animal-based antibody technologies.